Skip to content

Effect of prenatal administration of Lactobacillus Reuteri on prevention of Infantile Colic

comparison of the effectiveness of preinatal administration Lactobacillus Reuteri on prevention of Infantile Colic

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20131004014882N7
Enrollment
174
Registered
2019-09-08
Start date
2019-08-29
Completion date
Unknown
Last updated
2019-10-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infantile colic is an “irritable/uncontrollable/compulsive/inconsolable crying” for more than 3 hours a day, at least for three days a week, and for a week or longer in an infant without any distinct cause or failure to thrive. The onset and impoverishment of the symptoms must occur under 5 months of age in order for the condition to be definite as infantile colic.. Functional intestinal disorder, unspecified

Interventions

Intervention 1: Intervention group: Mothers who receive probiotics:87 pregnant mother at the last 4 weeks of pregnancy enter to the study. The probiotic drug (containing 100 million live L. Reuteri fr

Sponsors

Esfahan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 49 Years

Inclusion criteria

Inclusion criteria: The last 4 weeks of pregnancy The absence of a history of maternal immunocompromising conditions such as HIV The absence of maternal diabetes, hepatic and renal diseases, anemia (hemoglobin less than 10), bacterial or fungal infections, twins, maternal smoking history of 10 cigarettes per day, or administration of other probiotics Maternal age between 18 and 49 years old All pregnant mothers who have informed consent to participate in the study.

Exclusion criteria

Exclusion criteria: Mother hypersensitivity to any component of drug Mothers who are not willing to continue pregnancy or who have had an early pregnancy due to complications of pregnancy Preterm labor Mothers who do not receive the drug properly

Design outcomes

Primary

MeasureTime frame
The severity of colic. Timepoint: From birth to 5 months. Method of measurement: For the assessment colic severity, we used a validated Iranian questionnaire previously suggested by Famoori et al.;Infantile colic and severity. Timepoint: From birth to 5 months. Method of measurement: ?Defined by Wessel et al. and modified by ROME IV criteria as “irritable/uncontrollable/compulsive/inconsolable crying” for more than 3 hours a day, at least for three days a week, and for a week or longer in an infant without any distinct cause or failure to thrive. The onset and impoverishment of the symptoms must occur under 5 months of age in order for the condition to be definite as infantile colic.

Secondary

MeasureTime frame
Prevention or reduction of severity of infantile colic. Timepoint: Birth to 5 months. Method of measurement: questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Fateme Famoori

Esfahan University of Medical Sciences

fat.famoori@gmail.com+98 31 3668 0048

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026